https://biotechmorning.com/news/battery-less-brain-implant-ability-neurotech Biotech Morning en 2026-07-22T14:26:53.075Z The Brain Implant That Doesn't Need a Battery https://biotechmorning.com/news/repligen-biolife-solutions-acquisition-cell-therapy Biotech Morning en 2026-07-22T14:26:00.092Z Repligen Just Bought the Company That Keeps Cell Therapies Alive https://biotechmorning.com/news/fda-lost-3000-now-hiring-them-back Biotech Morning en 2026-07-22T14:25:07.995Z The FDA Lost 3,000 People. Now It Wants to Hire Them All Back. https://biotechmorning.com/news/novo-nordisk-sues-eli-lilly-glp1-advertising Biotech Morning en 2026-07-22T14:24:16.792Z Novo Nordisk Just Sued Eli Lilly. Yes, Over a Commercial. https://biotechmorning.com/news/allo-316-allogeneic-car-t-solid-tumor-remissions Biotech Morning en 2026-07-22T14:23:24.640Z The Off-the-Shelf Cancer Killer That Wasn't Supposed to Work https://biotechmorning.com/news/crystalys-gout-drug-dotinurad-series-b Biotech Morning en 2026-07-22T14:22:28.971Z This Gout Drug Already Works in Asia. Now It Wants America. https://biotechmorning.com/news/arpa-h-160m-genetic-medicine-platforms Biotech Morning en 2026-07-22T14:21:40.632Z Uncle Sam Just Bet $160M That Gene Therapy Can Work Like Software https://biotechmorning.com/news/jj-ottava-robotic-surgery-fda-authorization Biotech Morning en 2026-07-22T14:20:43.141Z J&J Just Built a Robot That Hides Under the Operating Table https://biotechmorning.com/news/alzheimers-drug-escaped-waiting-room Biotech Morning en 2026-07-22T14:19:51.054Z The Alzheimer's Drug That Just Escaped the Waiting Room https://biotechmorning.com/news/gsk-b7h3-adc-first-survival-win Biotech Morning en 2026-07-21T14:29:10.427Z GSK Just Won the First Survival Battle in Oncology's Hottest New Target Race https://biotechmorning.com/news/novartis-entresto-decline-q2-2026-earnings-beat Biotech Morning en 2026-07-21T14:28:11.263Z Novartis Just Lost Half Its Best-Seller. Wall Street Shrugged. https://biotechmorning.com/news/dyne-duchenne-drug-fda-fast-lane Biotech Morning en 2026-07-21T14:27:18.821Z Dyne's Duchenne Drug Just Got the FDA's Fast Lane https://biotechmorning.com/news/stargardt-disease-first-treatment-tinlarebant Biotech Morning en 2026-07-21T14:26:27.705Z The Eye Disease Nobody Could Treat Just Met Its Match https://biotechmorning.com/news/glp1-giants-novo-nordisk-sues-eli-lilly-false-advertising Biotech Morning en 2026-07-21T14:25:32.814Z The GLP-1 Giants Are Suing Each Other Now https://biotechmorning.com/news/tempus-ai-personalis-acquisition-oncology-data Biotech Morning en 2026-07-21T14:24:41.058Z Tempus AI Just Bet $1.5 Billion That It Can Own Cancer's Data Layer https://biotechmorning.com/news/biotech-cmo-fugitive-fake-identity Biotech Morning en 2026-07-21T14:23:47.597Z The Biotech CMO Who Didn't Exist https://biotechmorning.com/news/abbott-cyberattack-q2-earnings-july-2026 Biotech Morning en 2026-07-21T14:22:56.208Z Abbott's Hackers Claim 30 Million Records. Abbott Says Everything's Fine. https://biotechmorning.com/news/two-minutes-wegovy-telehealth-safety Biotech Morning en 2026-07-21T14:22:00.089Z Two Minutes to Decide If You Need Wegovy https://biotechmorning.com/news/ozempic-generic-semaglutide-canada-approval Biotech Morning en 2026-07-21T14:21:10.417Z Ozempic Just Lost Its Monopoly in a G7 Country https://biotechmorning.com/news/samsung-biologics-polypeptide-acquisition-glp1 Biotech Morning en 2026-07-21T14:20:19.619Z Samsung Biologics Just Made a $1.8 Billion Bet on Your Ozempic Supply Chain